Skip to main content
Clinical Trials/CTRI/2024/07/070193
CTRI/2024/07/070193Not yet recruitingPhase 2

Comparative evaluation of efficacy of doxycycline incorporated platelet rich fibrin (PRF-D) versus platelet rich fibrin (PRF) alone in the treatment of intrabony defects - A randomized control clinical trial - NI

DOGIPARTHI MOUNICA0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Periodontitis patients with the presence of intra-bony defect (IBD) =3 mm deep (distance between alveolar crest and base of the defect) on an intraoral periapical radiograph [IOPA].
  • 2.Interproximal probing depth (PD) =5 mm after phase I therapy in asymptomatic maxillary/ mandibular molar teeth.

Exclusion Criteria

  • 1.Patients with systemic conditions known to affect the periodontal status.
  • 2.Patients taking medications known to affect the outcomes of periodontal therapy.
  • 3.Pregnant and lactating women.
  • 4.Teeth with furcation defects, non-vital teeth, and mobility of at least grade II.
  • 5.History of periodontal surgery in past one year.
  • 6.Patients with unacceptable oral hygiene.
  • 7.Smokers.

Investigators

Sponsor
DOGIPARTHI MOUNICA

Similar Trials